Sustained release solid oral dosage forms: Single-unity or multiple-unity systems;Formas farmacêuticas sólidas orais de liberação prolongada: Sistemas monolíticos e multiparticulados

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 43, Issue 4, 2007, Pages 491-502

  Pezzini, Bianca Ramos ^a   Silva, Marcos Antônio Segatto ^b   Ferraz, Humberto Gomes ^c  

^a UNIVERSITY OF JOINVILLE REGION   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Multiple unity systems; Single unity systems; Solid oral dosage forms; Sustained release

Indexed keywords

ACECLOFENAC; BEZAFIBRATE; CARBAMAZEPINE; CLOMIPRAMINE; DEXCHLORPHENIRAMINE MALEATE; DICLOFENAC; DILTIAZEM; DILTIPRESS; FLODIN; FLUINDOSTATIN; GLICLAZIDE; HYDROCHLOROTHIAZIDE PLUS METOPROLOL; KETOPROFEN; LITHIUM CARBONATE; NIFEDIPINE; PAROXETINE; PROPRANOLOL; REBATEN; TOLTERODINE; UNCLASSIFIED DRUG; VENLAFAXINE; VERAPAMIL; VOLTAFLEX;

DRUG DOSAGE FORM; DRUG SOLUBILITY; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; REVIEW; RISK REDUCTION; SUSTAINED DRUG RELEASE;

EID: 42049106206     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. ALDERBORN, G. Comprimidos e compressão. In: AULTON, M. E. Delineamento de formas farmacêuticas. 2.ed. Porto Alegre: Artmed, 2005. cap.27, p.403-443.
2. ANSEL, H. C.; POPOVICH, N. G., ALLEN JR. L. V. Farmacoté cnica: formas farmacêuticas e sistemas de liberação de fármacos. 6.ed. São Paulo: Premier, 2000. 568 p.
3. ASHFORD, M. Biodisponibilidade - fatores físico-químicos e relacionados à forma farmacêutica. In: AULTON, M. E. Delineamento de formas farmacêuticas. 2.ed. Porto Alegre: Artmed, 2005. cap.17, p.245-263.
4. BETTINI, R.; CATELLANI, P. L.; SANTI, P.; PEPPAS, N. A.; COLOMBO, P. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J. Control. Release, Amsterdam, v.70, n.3, p.383-391, 2001.
5. BODMEIR, R. Tableting of coated pellets. Eur. J. Pharm. Biopharm., Stuttgart, v.43, n.1, p.1-8, 1997.
6. BORST, I.; UGWU, S.; BECKETT, A. H. New and extended applications for USP drug release apparatus 3. Dissolut. Technol., Hockessin, v.4, n.1, p.11-15, 1997.
7. ÇELIK, M. Compaction of multiparticulate oral dosage forms. In: GHEBRE-SELLASSIE, I. Multiparticle oral drug delivery. Nova York: Marcel Dekker, 1994. cap.9, p.215.
8. CHARMAN, S. A.; CHARMAN, W. N. Oral modified-release delivery systems. In: RATHBONE, M. J.; HADGRAFT, J.; ROBERTS, M. S., eds. Modified-release drug delivery technology. Nova York: Marcel Dekker, 2002. cap.1, p.1-10.
9. COLLETT, J; MORETON, C. Formas farmacêuticas perorais de liberação modificada. In: AULTON, M. E. Delineamento de formas farmacêuticas. 2.ed. Porto Alegre: Artmed, 2005. cap.20, p.299-313.
10. COLOMBO, P.; BETTINI, R.; SANTI, P.; PEPPAS, N. A. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. PSTT, Amsterdam, v.3, n.6, p.198-204, 2000.
11. COSTA, P.; LOBO, J. M. S. Formas farmacêuticas de liberação modificada. Rev. Port. Farm., Lisboa, v.49, n.4, p.181-190, 1999.
12. DAVIES, P. Oral solid dosage forms. In: GIBSON, M., ed. Pharmaceutical preformulation and formulation. Boca Raton: Interpharm/CRC, 2001. cap.11, p.379-458.
13. DE BRABANDER, C.; VERVAET, C.; FIERMANS, L.; REMON, J. P. Matrix mini-tablets based on starch:microcrystalline wax mixtures. Int. J. Pharm., Amsterdam, v.199, n.2, p.195-203, 2000.
14. EFENTAKIS, M.; KOUTLIS, A.; VLACHOU, M. Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems. AAPS PharmSciTech, Arlington, v.1, n.4, 2000. Disponível em: 〈http://www.aapspharmscietech.org〉. Acesso em: 24 jul. 2007.
15. GANDHI, R.; CHAMAN, L. K.; PANCHAGNULA, R. Extrusion and spheronization in the development of oral controlled-release dosage forms. PSTT, Amsterdam, v.2 n.4 p.160-170, 1999.
16. GHEBRE-SELLASSIE, I.; KNOCH, A. Pelletization techniques. In: SWARBRICK, J.; BOYLAN, J. C., (Eds.). Encyclopedia of pharmaceutical technology. 2.ed. Marcel Dekker: New York, 2002. v.3, p.2067-2080.
17. HICKS, D. C.; FREESE, H. L. Extrusion and spheronizing equipment. In: GHEBRE-SELLASSIE, I., ed. Pharmaceutical pelletization technology, 2 ed. Marcel Dekker: New York, 1989. cap.4, p.71-100.
18. JONES, D. M. Solution and suspension layering. In: GHEBRE-SELLASSIE, I., ed. Pharmaceutical pelletization technology. 2 ed. New York: Marcel Dekker, 1989. cap.7, p.145-164.
19. JORGENSEN, E. D.; BHAGWAT, D. Development of dissolution tests for oral extended-release products. PSTT, Amsterdam, v.1, n.3, p.128-135, 1998.
20. KHAN, G. M. Controlled release oral dosage forms: some recent advances in matrix type drug delivery systems. Science, v.1, n.5, p.350-354; 2001.
21. KRÄMER, J.; BLUME, H. Biopharmaceutical aspects of multiparticulates. In: GHEBRE-SELLASSIE, I. ed. Multiparticle oral drug delivery. New York: Marcel Dekker, 1994. cap.12, p.332.
22. KUMAR, M. N. V. R.; DOMB, A. J. Controlled drug delivery. In: WNEK, G. E.; BOWLIN, G. L., (Eds.). Encyclopedia of biomaterials and biomedical engineering. New York: Marcel Dekker, 2004. v.1, p.467-477.
23. LEE, T. W.; ROBINSON, J. R. Controlled-release drug-delivery systems. In: GENARO, A. R. ed. Remington: the science and practice of pharmacy. 20.ed. Baltimore: Lippincott Williams & Wilkins, 2000. cap.47, p.903-929.
24. LENNARTZ, P.; MIELCK, J. B. Minitabletting: improving the compactability of paracetamol powder mixtures. Int. J. Pharm., Amsterdam, v.173, n.1-2, p.75-85, 1998.
25. LIN, S.; LIN, K.; LI, M. Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: studies on micronized ethylcellulose for dosage form design (VII). AAPS Journal, Arlington, v.6, n. 3, 2004. Disponível em: 〈http://www.aapsj.org〉. Acesso em: 24 jul. 2007.
26. LOPES, C. M.; LOBO, J. M. S.; COSTA, P. Formas farmacêuticas de liberação modificada: polímeros hidrofílicos. Rev. Bras. Cien. Farm., São Paulo, v.41, n.2, p.455-470, 2005.
27. LORDI, N. G. Formas farmacêuticas de libertação prolongada. In: LACHMAN, L.; LIEBERMAN, H. A.; KANING, J. L. (Eds.). Teoria e prática na indústria farmacêutica. Lisboa: Fundação Calouste Gulbenkian, 2001. cap.14, p.737-781.
28. MU, X.; TOBYN, M. J.; STANIFORTH, J. N. Development and evaluation of bio- dissolution systems capable of detecting the food effect on a polysaccharide-based matrix system, J. Control. Release, Amsterdam, v.93, n.3, p.309-318, 2003.
29. NASTRUZZI, C.; CORTESI, R.; ESPOSITO, E.; GENOVESI, A.; SPADONI, A.; VECCHIO, C.; MENEGATTI, E. Influence of formulation and process parameters on pellet production by powder layering technique. AAPS PharmSciTech, Arlington, v.1, n.2, 2000. Disponível em: 〈http://www. aapspharmscietech.org〉. Acesso em: 24 jul. 2007.
30. QIU, Y.; ZHANG, G. Research and development aspects of oral controlled-release dosage forms. In: WISE, D. L. (Eds.). Handbook of pharmaceutical controlled release technology, New York: Marcel Dekker, 2000. cap.23, p.465-503.
31. RIBEIRO, L.; FERREIRA, D. C.; VEIGA, F. J. B. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets. J. Control. Release, Amsterdam, v.103, n.2, p.325-339, 2005.
32. SANTOS, H. M. M., VEIGA, F. J. B., PINA, M. E. T., SOUSA, J. J. M. S. Obtenção de pellets por extrusão e esferonização farmacêutica. Parte I. Avaliação das variáveis tecnológicas e de formulação. Rev. Bras. Cien. Farm., São Paulo, v.40, n.4, p.455-470, 2004.
33. SANTUS, G.; BAKER, R. W. Osmotic drug delivery: a review of the patent literature. J. Control. Release, Amsterdam, v.35, n.1, p.1-21, 1995.
34. SUMMERS, M.; AULTON, M. Granulação. In: AULTON, M. E., ed. Delineamento de formas farmacêuticas. 2.ed. Porto Alegre: Artmed, 2005. cap.25, p.370-383.
35. UNITED States Pharmacopoeia. 28.ed. Rockville: United States Pharmacopoeial Convention, 2005.
36. VENKATRAMAN, S.; DAVAR, N.; CHESTER, A.; KLEINER, L. An overview of controlled release systems. In: WISE, D. L., ed. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker, 2000. cap.22, p.431-463.
37. VERMA, R. K.; KRISHNA, D. M., GARG, S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Release, Amsterdam, v.79, n.1-3, p.7-27, 2002.
38. VERNON, B.; WEGNER, M. Controlled Release. In: WNEK, G. E.; BOWLIN, G. L., eds. Encyclopedia of Biomaterials and biomedical engineering. New York: Marcel Dekker, 2004. p.384-391.
39. VERVAET, C.; BAERT, L.; REMON, J. P. Extrusion-spheronisation: a literature review. Int. J. Pharm., Amsterdam, v.116, n.2, p.131-146, 1995.
40. WAGNER, K. G.; KRUMME, M.; SCHMIDT, P. C. Investigation of the pellet-distribution in single tablets via image analysis. Eur. J. Pharm. Biopharm., Stuttgart, v.47, n.1, p.79-85, 1999.
41. WANG, T.; TSUTSUMI, A.; HASEGAWA, H.; MINEO, T. Mechanism of particle coating granulation with RESS process in a fluidized bed. Powder Technol., Amsterdam, v.118, n.3, p.229-235, 2001.
42. WONG, P. S. L.; GUPTA, S. K.; STEWART, B. E. Osmotically Controled Tablets. In: RATHBONE, M. J.; HADGRAFT, J.; ROBERTS, M. S., eds. Modified-release drug delivery technology. New York: Marcel Dekker, 2002. cap. 9, p.101-114.
43. YORK, P. Delineamento de formas farmacêuticas. In: AULTON, M. E., eds. Delineamento de formas farmacêuticas. 2.ed. Porto Alegre: Artmed, 2005. cap.1, p.17-28.
44. YU, L. X.; WANG, J. T.; HUSSAIN, A. S. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products. AAPS PharmSci, Arlington, v.4, n.1, 2002. Disponível em: 〈http://www.aapsj. org〉. Acesso em: 24 Jul. 2007.